The Scientist

» Sweden and genetics & genomics

Most Recent

image: The Challenges of Precision

The Challenges of Precision

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: To Each His Own

To Each His Own

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

0 Comments

image: Two-Faced RNAs

Two-Faced RNAs

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

0 Comments

image: From Many, One

From Many, One

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

4 Comments

image: Resisting Cancer

Resisting Cancer

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

7 Comments

image: Hiding in Plain Sight

Hiding in Plain Sight

By | March 31, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Genome Nation

Genome Nation

By | March 27, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

0 Comments

image: “Yeti” Just a Himalayan Bear?

“Yeti” Just a Himalayan Bear?

By | March 17, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

0 Comments

image: 23andMe Enters Drug Development

23andMe Enters Drug Development

By | March 12, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

4 Comments

image: Horizontal Gene Transfer a Hallmark of Animal Genomes?

Horizontal Gene Transfer a Hallmark of Animal Genomes?

By | March 12, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

4 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech